Bibimariyam Nasyrlaeva
Research Subjects
Bibimariyam Nasyrlaeva has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Azadeh Khayyat
Internal Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IRN
1 shared publication - Irina Balan
Internal Medicine, Nicolae Testemițanu State University of Medicine and Pharmacy, Chisinau, MDA
1 shared publication - Laseena Vaisyambath
Department of Medicine, Markham Stouffville Hospital, Markham, ON L3P7P3, Canada
1 shared publication - Muhammad Asad
Department of Pathology and Laboratory Medicine, Weill Cornell Medical Center, New York Presbyterian Hospital, New York, NY 10065, USA
1 shared publication - Nkechinyere Unachukwu
Department of Internal Medicine, Interfaith Medical Center, Brooklyn, NY 11213, USA
1 shared publication - Richa Jaiswal
Department Internal Medicine, Medical University of South Carolina, Charleston, USA
1 shared publication
Latest Publications
- Open Access
- 9 May 2022
- Published by Springer Nature in Cureus
- Vol. 14 (5) , e24850
Cardiac Sarcoidosis Diagnostic Challenges and Management: A Case Report and Literature Review
Sarcoidosis can be presented as cardiac sarcoidosis (CS), which is challenging to diagnose due to its clinical silence. Ventricular arrhythmias and atrioventricular blocks can be fatal and cause sudden death in patients with cardiac sarcoidosis. Five percent of sarcoidosis patients have clinically evident cardiac sarcoidosis. However, autopsy reports and imaging studies have shown a higher prevalence of cardiac involvement. Early recognition is important to prevent such detrimental consequences. Cardiac sarcoidosis is increasingly being diagnosed owing to increased awareness among physicians and new diagnostic tools like MRI and positron emission tomography (PET) scan replacing traditional endomyocardial biopsy. A definitive diagnosis of CS remains challenging due to the non-specific clinical findings that can present similar symptoms of common cardiac disease; therefore, the imaging and biopsies are substantial for diagnosis confirmation. Pharmacological and Implantable devices are two main therapeutic approaches in cardiac sarcoidosis, in which steroids and pacemaker therapy have shown better outcomes. This review summarizes the available data related to the prevalence, prognosis, diagnosis, and management of cardiac sarcoidosis.
- 9 May 2022
- Published by Springer Nature in Cureus
- Vol. 14 (5) , e24850
Open AccessCardiac Sarcoidosis Diagnostic Challenges and Management: A Case Report and Literature Review
Sarcoidosis can be presented as cardiac sarcoidosis (CS), which is challenging to diagnose due to its clinical silence. Ventricular arrhythmias and atrioventricular blocks can be fatal and cause sudden death in patients with cardiac sarcoidosis. Five percent of sarcoidosis patients have clinically evident cardiac sarcoidosis. However, autopsy reports and imaging studies have shown a higher prevalence of cardiac involvement. Early recognition is important to prevent such detrimental consequences. Cardiac sarcoidosis is increasingly being diagnosed owing to increased awareness among physicians and new diagnostic tools like MRI and positron emission tomography (PET) scan replacing traditional endomyocardial biopsy. A definitive diagnosis of CS remains challenging due to the non-specific clinical findings that can present similar symptoms of common cardiac disease; therefore, the imaging and biopsies are substantial for diagnosis confirmation. Pharmacological and Implantable devices are two main therapeutic approaches in cardiac sarcoidosis, in which steroids and pacemaker therapy have shown better outcomes. This review summarizes the available data related to the prevalence, prognosis, diagnosis, and management of cardiac sarcoidosis.